GSK Investigational Site
Buenos Aires, Buenos Aires CP1431FWO
0 studies enrolling now · 19 studies all time
What they study most
Anxiety Disorders, Asthma, Atherosclerosis, Atrial Fibrillation, Diabetes Mellitus, Type 2, Epilepsy, Tonic-Clonic, Fibrillation, Atrial, Neoplasms, Breast, Prostatic Hyperplasia, Pulmonary Disease, Chronic Obstructive, Rhinitis, Allergic, Perennial, Skin Infections, Bacterial
Studies at this site
- Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early
- Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug — Completed
- 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease — Completed
- Study In People With Type 2 Diabetes — Completed
- SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed
- Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
- Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
- Perennial Allergic Rhinitis Study In Pediatric Subjects — Completed
- HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents — Completed
- Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke — Completed
- Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma. — Completed
- A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma — Completed
- A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma — Completed
- A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin — Completed
- Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) — Completed
- A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder — Completed
- Advair Pediatric Once-Daily — Completed
- SB-480848 In Subjects With Coronary Heart Disease — Completed
- Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer — Completed